Argenx
ARGX
#407
Rank
NZ$107.54 B
Marketcap
NZ$1,729
Share price
-3.37%
Change (1 day)
44.36%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report